Education
About Us
Working with TipRanks
Follow Us
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
RESEARCH TOOLSreports
Technical Sentiment
Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Dermata Therapeutics’s (DRMA) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Dermata Therapeutics is a Buy.
Dermata Therapeutics’s (DRMA) 20-Day exponential moving average is 1.14, while Dermata Therapeutics’s (DRMA) share price is $0.96, making it a Sell.
Dermata Therapeutics’s (DRMA) 50-Day exponential moving average is 1.19, while Dermata Therapeutics’s (DRMA) share price is $0.96, making it a Sell.
Dermata Therapeutics (DRMA) Pivot Points
Classic
0.88
0.97
1.02
1.11
1.16
1.25
1.30
Fibonacci
0.97
1.02
1.05
1.11
1.16
1.19
1.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Dermata Therapeutics (DRMA) Moving Averages
MA5
0.99Sell
1.01Sell
MA10
1.16Sell
1.09Sell
MA20
1.18Sell
1.14Sell
MA50
1.18Sell
1.19Sell
MA100
1.21Sell
1.33Sell
MA200
1.54Sell
1.89Sell
Dermata Therapeutics’s (DRMA) 10-Day exponential moving average is 1.09, while Dermata Therapeutics’s (DRMA) share price is $0.96, making it a Sell.
Dermata Therapeutics’s (DRMA) 100-Day exponential moving average is 1.33, while Dermata Therapeutics’s (DRMA) share price is $0.96, making it a Sell.
Dermata Therapeutics’s (DRMA) stock price is $0.96 and Dermata Therapeutics’s (DRMA) 50-day simple moving average is 1.18, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $0.96 and Dermata Therapeutics’s (DRMA) 100-day simple moving average is 1.21, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $0.96 and Dermata Therapeutics’s (DRMA) 200-day simple moving average is 1.54, creating a Sell signal.
Dermata Therapeutics (DRMA) Technical Indicators
RSI (14)
36.33
Neutral
STOCH (9,6)
1.60
Buy
STOCHRSI (14)
1.87
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
38.01
Neutral
Williams %R
-99.93
Buy
CCI (14)
-158.15
Buy
ATR (14)
0.16
-
Ultimate Oscillator
19.63
Sell
ROC
-17.95
Sell
Dermata Therapeutics’s (DRMA) Relative Strength Index (RSI) is 36.33, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Trend Strength Indicator (ADX) is 38.01, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Commodity Channel Index (CCI) is -158.15, creating a Buy signal.
Dermata Therapeutics’s (DRMA) Price Rate of Change (ROC) is -17.95, creating a Sell signal.
FAQ
Is DRMA a Buy, Hold, or Sell?
Based on DRMA’s technical indicators, DRMA is a Strong Sell.
What is DRMA’s RSI (14)?
DRMA’s RSI (14) is 36.33, which suggests DRMA is a Neutral.
What is DRMA’s MACD?
DRMA’s MACD is >-0.01, which suggests DRMA is a Buy.
What is DRMA’s 5-day moving average?
DRMA’s 5-day moving average is 0.99, which suggests DRMA is a Sell.
What is DRMA’s 20-day moving average?
DRMA 20-day moving average is 1.18, which suggests DRMA is a Sell.
What is DRMA’s 50-day moving average?
DRMA’s 50-day moving average is 1.18, which suggests DRMA is a Sell.
What is DRMA’s 200-day moving average?
DRMA’s 200-day moving average is 1.54, which suggests DRMA is a Sell.
What is DRMA’s Williams % R (14)?
DRMA’s Williams % R (14) is -99.93, which suggests DRMA is a Buy.
What is DRMA’s CCI (14)?
DRMA’s CCI (14) is -158.15, which suggests DRMA is a Buy.